Concert Pharmaceuticals (NASDAQ:CNCE)

CAPS Rating: 3 out of 5

Caps

How do you think CNCE will perform against the market?

Add Stock to CAPS Watchlist

All Players

23 Outperform
2 Underperform
 

All-Star Players

7 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top CNCE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CNCE VS S&P 500 (SPY)

CNCE Summary

Fools bearish on CNCE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CNCE.

Recs

0
Member Avatar Paco57 (43.32) Submitted: 12/19/2017 11:09:36 PM : Outperform Start Price: $29.28 CNCE Score: -34.78

It's so obvious.

Recs

0
Member Avatar healthcarevalue (92.40) Submitted: 12/13/2017 3:10:54 PM : Outperform Start Price: $26.75 CNCE Score: -28.67

Debt equity ratio of negligible to zero. Price earnings ratio below seven. Return on Invested Capital last Twelve Trailing Months of just about sixty two percent. Market capitalization of about six hundred and ten million dollars leaves potential to be acquired. Trading at low end of fifty two week range between seven and twenty seven. Niche biopharmaceutical company, with focus on areas attractive to baby boomer demographic including inflammatory diseases and autoimmune diseases.

Recs

0
Member Avatar KenCam21 (65.20) Submitted: 5/6/2016 9:06:32 AM : Outperform Start Price: $11.84 CNCE Score: +33.99

I almost selected Underperform on principle, but the balance sheet looks.....kind of good.

Leaderboard

Find the members with the highest scoring picks in CNCE.

Score Leader

gunda7907

gunda7907 (< 20) Score: +114.80

The Score Leader is the player with the highest score across all their picks in CNCE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
gunda7907 < 20 10/31/2016 Outperform 5Y $7.76 +159.66% +30.72% +128.94 0 Comment
JimAnder 69.66 7/17/2014 Outperform 5Y $8.40 +139.88% +40.83% +99.06 0 Comment
efarev 98.87 9/22/2016 Outperform 5Y $10.14 +98.72% +27.84% +70.87 0 Comment
KenCam21 65.20 5/6/2016 Outperform 3Y $11.84 +70.19% +36.20% +33.99 1 Comment
drugtrader 95.45 1/4/2018 Underperform 5Y $27.46 -26.62% +2.28% +28.90 0 Comment
clangmead 61.63 8/30/2017 Outperform 5Y $14.72 +36.89% +13.52% +23.37 0 Comment
hayrettin 70.71 10/19/2017 Outperform 5Y $15.27 +31.96% +8.83% +23.13 0 Comment
portefeuille2 99.40 8/29/2017 Outperform 5Y $14.93 +34.96% +13.62% +21.35 0 Comment
PAGEBOY73 98.76 8/31/2017 Outperform NS $15.13 +33.18% +12.48% +20.70 0 Comment
DayTradeMen 56.10 3/6/2017 Outperform 3W $15.47 +30.25% +16.74% +13.51 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CNCE.

Featured Broker Partners